Itovebi, approved for some patients with breast cancer, is the first PI3K inhibitor to display a survival benefit, according ...

Dr. Kevin Kalinsky covers the gamut of the current treatment landscape for patients with HER2-negative breast cancer, ...

Breast carcinoma remains the most common malignancy of women around the world, and despite the advances in the early diagnosis and adjuvant treatment of this disease, many women still relapse with ...

The Fellows of the AACR Academy have elected Elaine V. Fuchs, PhD, FAACR, as their next President. She will assume the ...

After hours: March 19 at 6:45:37 PM EDT Loading Chart for CRIS ...

Onctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, today announces it has dosed the first patient in the randomized Phase II OCULE-01 study ...

Chelsea Rae Bourgeois is a health writer and registered dietitian nutritionist with over eight years of experience in the clinical setting. Her writing covers nutrition and overall health topics ...

Cute animated tale with some mild peril and scary bugs.

In the ever-evolving field of new drug development, genetics and network pharmacology have emerged as two pivotal elements that are revolutionizing the traditional paradigm of drug research and ...

CHANDLER, AZ (AZFamily) — A shooting at a Chandler apartment complex put a man in the hospital on Friday night. It happened at the Riveria Park Apartments on Dobson Road, south of Chandler ...